Kizoo Technology Capital is a Germany-based venture capital firm focused on early-stage investments in biotechnology, with a particular emphasis on longevity and rejuvenation science. The firm supports startups developing therapies aimed at addressing the biological causes of aging and age-related diseases. It provides seed funding, follow-on capital, and mentoring to entrepreneurial teams. Kizoo operates as part of a broader ecosystem dedicated to extending healthy human lifespan. Its investment approach combines scientific focus with long-term technological impact.